Viruses use polymerases to replicate their genomes. Because polymerases are designed to process nucleosides and nucleotides, mimics of these structures have great potential as antiviral agents. For example, the recently-approved anti-Covid drug remdesivir is a nucleotide mimic. The Langenhan Laboratory is working to synthesize a novel class of nucleoside mimics and to test their activity against viruses.